This inventor holds 2 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1976-1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Takatsuki, JA (1976)
- Nagaokakyo, JP (1980)
Company Filing History:
Years Active: 1976-1980
Title: Masatsugu Tomita: Innovator in Pharmaceutical Chemistry
Introduction
Masatsugu Tomita is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antibacterial compounds and methods for determining lipase activity. With a total of 2 patents, his work has had a meaningful impact on medical science.
Latest Patents
Tomita's latest patents include innovative compounds and methods. One of his patents focuses on substituted 7[s-oxopyrido[2,3-d]pyrimidine carboxamido - Cephalosporin compounds. These compounds exhibit superior antibacterial activity and excellent solubility in aqueous media, making them useful as antibacterial agents. Another patent involves a reagent for determining lipase activity, which utilizes S-acyl compounds to react with lipase in a buffer solution. This method allows for accurate colorimetric determination of lipase activity.
Career Highlights
Masatsugu Tomita is associated with Dainippon Pharmaceutical Company, Limited, where he has been able to apply his expertise in pharmaceutical innovations. His work has contributed to advancements in drug development and therapeutic applications.
Collaborations
Tomita has collaborated with notable colleagues in his field, including Yoshiyuki Takase and Toshio Komiya. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Masatsugu Tomita's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and antibacterial treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
